BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2007
View Archived Issues
Preclinical profile of novel oncolytic measles virus
Read More
Vivus initiates phase III CONQUER trial of Qnexa in obese patients
Read More
Schering-Plough acquires Organon BioSciences from Akzo Nobel for EUR 11 billion
Read More
Aradigm initiates phase II trial of inhaled liposomal ciprofloxacin for cystic fibrosis
Read More
BioAlliance completes patient enrollment in phase III clinical trial of Loramyc
Read More
Sinovac provides update on clinical trials of H5N1 pandemic influenza vaccines
Read More
Clinical trials show anti-hepatitis C virus activity of telaprevir therapy
Read More
Antimalarial noninferiority of Coarsucam and Coartem demonstrated
Read More
Nitazoxanide improves responses to standard care in HCV genotype 4 patients
Read More
Objective responses seen with SGN-35 in phase I Hodgkin's lymphoma study
Read More
Raven updates phase I clinical trial results of RAV-12
Read More
Sanofi-aventis presents third quarter 2007 results
Read More
Recent patents disclose novel analgesic agents
Read More
The FDA accepts for filing CV Therapeutics' sNDA and NDA for Ranexa
Read More
Amarin completes data review of phase III TREND-HD clinical trial of Miraxion
Read More
Studies reveal efficacy of golimumab in ankylosing spondylitis, psoriatic arthritis
Read More
Improvement seen with baminercept in rheumatoid arthritis patients
Read More
Antichlamydial treatment does not improve intermittent claudication symptoms
Read More
First-in-human study assesses effects of SB-705498 on pain, hyperalgesia
Read More
Tiagabine ineffective in cocaine dependence study
Read More
Topigen initiates phase II proof-of-concept trial of TPI-1020 for COPD
Read More
Biogen Idec and Neurimmune enter agreement for antibodies for Alzheimer's disease
Read More
Pacgen initiates phase IIb clinical trial of PAC-113 for oral candidiasis
Read More
GSK and Genmab initiate two phase III studies of ofatumumab in rheumatoid arthritis
Read More
Antisoma provides update on clinical development of its anticancer compounds
Read More
Array BioPharma initiates phase II trial of ARRY-797 for dental pain
Read More
Cytochroma initiates phase I/II clinical trial of CTAP-101 capsules
Read More
Novartis withdraws application to extend marketing authorization for Zometa
Read More
Recent GSK patents impart new agents for HIV infection
Read More
New diagnostic agents reported in recent U.S. Department of Health & Human Services patent
Read More